Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

70 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Validated machine learning tools to distinguish immune checkpoint inhibitor, radiotherapy, COVID-19 and other infective pneumonitis.
Hindocha S, Hunter B, Linton-Reid K, George Charlton T, Chen M, Logan A, Ahmed M, Locke I, Sharma B, Doran S, Orton M, Bunce C, Power D, Ahmad S, Chan K, Ng P, Toshner R, Yasar B, Conibear J, Murphy R, Newsom-Davis T, Goodley P, Evison M, Yousaf N, Bitar G, McDonald F, Blackledge M, Aboagye E, Lee R. Hindocha S, et al. Among authors: locke i. Radiother Oncol. 2024 Jun;195:110266. doi: 10.1016/j.radonc.2024.110266. Epub 2024 Apr 4. Radiother Oncol. 2024. PMID: 38582181 Free article.
Immune Checkpoint Inhibitor and Radiotherapy-Related Pneumonitis: An Informatics Approach to Determine Real-World Incidence, Severity, Management, and Resource Implications.
Hindocha S, Campbell D, Ahmed M, Giorgakoudi K, Sharma B, Yousaf N, Molyneaux P, Hunter B, Kalsi H, Cui W, Davidson M, Bhosle J, Minchom A, Locke I, McDonald F, O'Brien M, Popat S, Lee RW. Hindocha S, et al. Among authors: locke i. Front Med (Lausanne). 2021 Nov 1;8:764563. doi: 10.3389/fmed.2021.764563. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34790682 Free PMC article.
A comparison of machine learning methods for predicting recurrence and death after curative-intent radiotherapy for non-small cell lung cancer: Development and validation of multivariable clinical prediction models.
Hindocha S, Charlton TG, Linton-Reid K, Hunter B, Chan C, Ahmed M, Robinson EJ, Orton M, Ahmad S, McDonald F, Locke I, Power D, Blackledge M, Lee RW, Aboagye EO. Hindocha S, et al. Among authors: locke i. EBioMedicine. 2022 Mar;77:103911. doi: 10.1016/j.ebiom.2022.103911. Epub 2022 Mar 3. EBioMedicine. 2022. PMID: 35248997 Free PMC article.
Gross tumour volume radiomics for prognostication of recurrence & death following radical radiotherapy for NSCLC.
Hindocha S, Charlton TG, Linton-Reid K, Hunter B, Chan C, Ahmed M, Greenlay EJ, Orton M, Bunce C, Lunn J, Doran SJ, Ahmad S, McDonald F, Locke I, Power D, Blackledge M, Lee RW, Aboagye EO. Hindocha S, et al. Among authors: locke i. NPJ Precis Oncol. 2022 Oct 27;6(1):77. doi: 10.1038/s41698-022-00322-3. NPJ Precis Oncol. 2022. PMID: 36302938 Free PMC article.
Author Correction: Gross tumour volume radiomics for prognostication of recurrence & death following radical radiotherapy for NSCLC.
Hindocha S, Charlton TG, Linton-Reid K, Hunter B, Chan C, Ahmed M, Greenlay EJ, Orton M, Bunce C, Lunn J, Doran SJ, Ahmad S, McDonald F, Locke I, Power D, Blackledge M, Lee RW, Aboagye EO. Hindocha S, et al. Among authors: locke i. NPJ Precis Oncol. 2022 Nov 23;6(1):87. doi: 10.1038/s41698-022-00332-1. NPJ Precis Oncol. 2022. PMID: 36418522 Free PMC article. No abstract available.
Real-world outcomes in thoracic cancer patients with severe Acute respiratory syndrome Coronavirus 2 (COVID-19): Single UK institution experience.
Cui W Dr, Yousaf N Dr, Bhosle J Dr, Minchom A Dr, Nicholson AG Prof, Ahmed M Dr, McDonald F Dr, Locke I Dr, Lee R Dr, O'Brien M Prof, Popat S Prof. Cui W Dr, et al. Among authors: locke i dr. Cancer Treat Res Commun. 2020;25:100261. doi: 10.1016/j.ctarc.2020.100261. Epub 2020 Dec 2. Cancer Treat Res Commun. 2020. PMID: 33310368 Free PMC article.
A Comparison of Isotoxic Dose-escalated Radiotherapy in Lung Cancer with Moderate Deep Inspiration Breath Hold, Mid-ventilation and Internal Target Volume Techniques.
Bainbridge H, Dunlop A, McQuaid D, Gulliford S, Gunapala R, Ahmed M, Locke I, Nill S, Oelfke U, McDonald F. Bainbridge H, et al. Among authors: locke i. Clin Oncol (R Coll Radiol). 2022 Mar;34(3):151-159. doi: 10.1016/j.clon.2021.08.012. Epub 2021 Sep 7. Clin Oncol (R Coll Radiol). 2022. PMID: 34503896
Systemic treatment of brain metastases in non-small cell lung cancer.
Page S, Milner-Watts C, Perna M, Janzic U, Vidal N, Kaudeer N, Ahmed M, McDonald F, Locke I, Minchom A, Bhosle J, Welsh L, O'Brien M. Page S, et al. Among authors: locke i. Eur J Cancer. 2020 Jun;132:187-198. doi: 10.1016/j.ejca.2020.03.006. Epub 2020 May 4. Eur J Cancer. 2020. PMID: 32380429 Review.
The UK HeartSpare Study (Stage IB): randomised comparison of a voluntary breath-hold technique and prone radiotherapy after breast conserving surgery.
Bartlett FR, Colgan RM, Donovan EM, McNair HA, Carr K, Evans PM, Griffin C, Locke I, Haviland JS, Yarnold JR, Kirby AM. Bartlett FR, et al. Among authors: locke i. Radiother Oncol. 2015 Jan;114(1):66-72. doi: 10.1016/j.radonc.2014.11.018. Epub 2014 Nov 26. Radiother Oncol. 2015. PMID: 25739317 Clinical Trial.
70 results